Clinical Research Center of Houston
Many doctors at OGA have a history of conducting clinical trials using staff in their practices, and have been quite effective in running trials in this manner. By forming the Clinical Research Center of Houston at OGA, and creating a resource of people specialized in conducting clinical trials, we are formally demonstrating our commitment to excellence in clinical research, as well as to patient care. The Clinical Research Center of Houston brings specialized skills to the conduct of clinical trials. It is able to get them started quicker, to ensure that the objectives of the trial are met and to reduce the likelihood that patients are not lost to follow-up. Since we are recruiting from the practices of physicians at OGA, this also allows us access to a more accurate medical history as compared to enrolling people recruited from outside advertising.
We are currently recruiting for clinical trials in the following areas:
Menopause
- Menopausal women (natural or surgical) between the ages of 30 and 65
- Has symptoms of estrogen and/or androgen deficiency not currently controlled by standard estrogen therapy
- Should have persistent menopause symptoms and currently on estrogen therapy
- Study length 18-20 weeks
Secondary Amenorrhea
- Women 18 to 45 years old
- With secondary amenorrhea (hypothalmic amenorrhea or ovarian failure) of at least 90 days duration OR
- Have been diagnosed with secondary amenorrhea and placed on hormone therapy
- Study length three 28-day cycles
Breast Cancer Detection
- Subject is scheduled for routine bilateral screening mammogram
- Has no prior breast biopsies
- Scan preferably completed on same day and prior to mammogram
- Scan may be performed up to 90 days or less before or after mammogram
- Scan is similar to EKG (heart tracing)
Risk Reduction Of Preterm Delivery In Pregnant Women At Increased-Risk For Preterm Delivery
- Pregnant subjects between 18 and 45 years old
- At high risk of spontaneous preterm delivery
- Duration of treatment approximately 14-19 weeks
- Treatment with progesterone gel
Breast Scan As Potential Adjunct To Mammography In Women With Suspicious Mammograms
- Women 18 to 50 years old
- Current mammogram is indeterminate or suspicious and indicates a need for a breast biopsy
Rapid Test For Detection of Group B Streptococcus In Pregnant Women
- Pregnant women at 35-37 weeks gestation
- Not currently being treated with antibiotics
- No presence of placenta previa
If you are interested in participating in any of these
studies,
please contact or office at (713) 512-7724
Copyright 2005 Obstetrical and Gynecological Associates, PA ©